about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
1.19
-0.01
(-0.83%)
64,111
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for MetaVia Inc took place on 14 May 2026, for the purpose of MetaVia Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
MetaVia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..